b 2-1 Fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge : results from a randomised controlled trial

@inproceedings{Lomax2012b2F,
  title={b 2-1 Fructans have a bifidogenic effect in healthy middle-aged human subjects but do not alter immune responses examined in the absence of an in vivo immune challenge : results from a randomised controlled trial},
  author={Amy R. Lomax and Lydia V. Y. Cheung and Kieran M Tuohy and Paul Stanton Noakes and Elizabeth A. Miles and Phillip C Calder},
  year={2012}
}
b2-1 fructans are considered to be prebiotics. Current literature indicates that b2-1 fructans may modulate some aspects of immune function, improve the host’s ability to respond to certain intestinal infections, and modify some inflammatory outcomes in human subjects. However, there is a need to find out more about the modulation of immune markers by b2-1 fructans in humans. Healthy human subjects aged 45–65 years were randomly allocated to b2-1 fructans (Orafti Synergy1; 8 g/d; n 22) or the… CONTINUE READING